Umbilical cord derived mesenchymal stem cells(Qilu Stem Cells Engineering)

N/A

Report date: 2023/04/04 20:00:35

Base Information

Drug NameUmbilical cord derived mesenchymal stem cells(Qilu Stem Cells Engineering)
Drug Alias NameUC-MSC - Qilu Stem Cells Engineering
ClassificationCell and gene therapy > Cell therapy > Source of cells > Umbilical cord-derivedCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapy
Mechanisms of ActionStem cell replacements
TargetsNot applicable
Therapy Area/IndicationsBone Marrow Failure Disorders
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesShandong Qilu Stem Cells Engineering Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesShandong Qilu Stem Cells Engineering Co Ltd
Inactive CompaniesN/A
Active IndicationsBone Marrow Failure Disorders
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A